Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy
Hui-Ming Chen*, Ma, G.*, Gildener-Leapman, N., Eisenstein, S., Coakley, B.A., Ozao, J., Mandeli, J., Divino, C., Schwartz, M., Sung, M., Ferris, R., Kao, J., Wang, L.H., Pan, P.Y., Ko, E.C, & Chen, S.H. *: Equal contribution. (2015) Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy Clinical Cancer Research, 21(18), p4073-4085. PMCID: PMC4720266